Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Chung, Myung Chul ^a   Tonry, Jessica H ^a   Narayanan, Aarthi ^a   Manes, Nathan P ^a   Mackie, Ryan S ^b   Gutting, Bradford ^b   Mukherjee, Dhritiman V ^a   Popova, Taissia G ^a   Kashanchi, Fatah ^a   Bailey, Charles L ^a   Popov, Serguei G ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b NAVAL SURFACE WARFARE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; COMPLEMENT COMPONENT C3B; ELONGATION FACTOR TU; LYSINE; PLASMIN; PLASMINOGEN; PLASMINOGEN RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; OPSONIN; RECOMBINANT PROTEIN; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; CONTROLLED STUDY; HOST PATHOGEN INTERACTION; IN VITRO STUDY; INNATE IMMUNITY; LUNG LAVAGE; MACROPHAGE FUNCTION; MICROBIAL ACTIVITY; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN INTERACTION; ANIMAL; CELL LINE; CELL MEMBRANE; CYTOLOGY; DRUG EFFECT; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; RABBIT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BACILLUS ANTHRACIS; ORYCTOLAGUS CUNICULUS;

ANIMALS; BACILLUS ANTHRACIS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CELL MEMBRANE; COMPLEMENT C3B; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FIBRINOLYSIN; HUMANS; IMMUNITY, INNATE; MACROPHAGES; MICE; OPSONIN PROTEINS; PHAGOCYTOSIS; PLASMINOGEN; PROTEIN BINDING; RABBITS; RECOMBINANT PROTEINS; SPORES, BACTERIAL; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 79953041830     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018119     Document Type: Article

References (60)

1. Dixon TC, Meselson M, Guillemin J, Hanna PC, (1999) Anthrax. N Engl J Med 341: 815-826.
2. Guidi-Rontani C, (2002) The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends Microbiol 10: 405-409.
3. Guidi-Rontani C, Weber-Levy M, Labruyère E, Mock M, (1999) Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol 31: 9-17.
4. Park JM, Greten FR, Li Z, Karin M, (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297: 2048-2051.
5. Brittingham KC, Ruthel G, Panchal RG, Fuller CL, Ribot WJ, et al. (2005) Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol 174: 5545-5552.
6. Comer JE, Chopra AK, Peterson JW, König R, (2005) Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect Immun 73: 8275-8281.
7. Shaw CA, Starnbach MN, (2008) Both CD4+ and CD8+ T cells respond to antigens fused to anthrax lethal toxin. Infect Immun 76: 2603-2611.
8. Cowan GJM, Atkins HS, Johnson LK, Titball RW, Mitchell TJ, (2007) Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis. Vaccine 25: 7197-7205.
9. Blom AM, Hallström T, Riesbeck K, (2009) Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol Immunol 46: 2808-2817.
10. Lambris JD, Ricklin D, Geisbrecht BV, (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6: 132-142.
11. Kraiczy P, Würzner R, (2006) Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol 43: 31-44.
12. Russell BH, Vasan R, Keene DR, Xu Y, (2007) Bacillus anthracis internalization by human fibroblasts and epithelial cells. Cell Microbiol 9: 1262-1274.
13. Glomski IJ, Piris-Gimenez A, Huerre M, Mock M, Goossens PL, (2007) Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 3: e76.
14. Vieira ML, Vasconcellos SA, Gonçales AP, de Morais ZM, Nascimento ALTO, (2009) Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation. Infect Immun 77: 4092-4101.
15. Chung MC, Popova TG, Millis BA, Mukherjee DV, Zhou W, et al. (2006) Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors. J Biol Chem 281: 31408-31418.
16. Grosskinsky S, Schott M, Brenner C, Cutler SJ, Kraiczy P, et al. (2009) Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. PLoS ONE 4: e4858.
17. Kunert A, Losse J, Gruszin C, Hühn M, Kaendler K, Mikkat S, Volke D, et al. (2007) Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol 179: 2979-2988.
18. Mukhopadhyay S, Akmal A, Stewart AC, Hsia R, Read TD, (2009) Identification of Bacillus anthracis spore component antigens conserved across diverse Bacillus cereus sensu lato strains. Mol Cell Proteomics 8: 1174-1191.
19. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S, (1981) Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41: 4629-4636.
20. Ferguson JS, Weis JJ, Martin JL, Schlesinger LS, (2004) Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect Immun 72: 2564-2573.
21. Premanandan C, Storozuk CA, Clay CD, Lairmore MD, Schlesinger LS, et al. (2009) Complement protein C3 binding to Bacillus anthracis spores enhances phagocytosis by human macrophages. Microb Pathog 46: 306-314.
22. Welkos SL, Keener TJ, Gibbs PH, (1986) Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 51: 795-800.
23. Harvill ET, Lee G, Grippe VK, Merkel TJ, (2005) Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis Sterne strain. Infect Immun 73: 4420-4422.
24. Agarwal S, Kulshreshtha P, Bambah Mukku D, Bhatnagar R, (2008) alpha-Enolase binds to human plasminogen on the surface of Bacillus anthracis. Biochim Biophys Acta 1784: 986-994.
25. Matta SK, Agarwal S, Bhatnagar R, (2010) Surface localized and extracellular Glyceraldehyde-3-phosphate dehydrogenase of Bacillus anthracis is a plasminogen binding protein. Biochim Biophys Acta 1804: 2111-2120.
26. Boydston JA, Chen P, Steichen CT, Turnbough CL Jr, (2005) Orientation within the exosporium and structural stability of the collagen-like glycoprotein BclA of Bacillus anthracis. J Bacteriol 187: 5310-5317.
27. Sylvestre P, Couture-Tosi E, Mock M, (2002) A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol Microbiol 45: 169-178.
28. Redmond C, Baillie LW, Hibbs S, Moir AJ, Moir A, (2004) Identification of proteins in the exosporium of Bacillus anthracis. Microbiology 150: 355-363.
29. Gadjeva M, Dodds AW, Taniguchi-Sidle A, Willis AC, Isenman DE, et al. (1998) The covalent binding reaction of complement component C3. J Immunol 161: 985-990.
30. Sim RB, Twose TM, Paterson DS, Sim E, (1981) The covalent-binding reaction of complement component C3. Biochem J 193: 115-127.
31. Mueller-Ortiz SL, Wanger AR, Norris SJ, (2001) Mycobacterial protein HbhA binds human complement component C3. Infect Immun 69: 7501-7511.
32. Gatfield J, Pieters J, (2003) Molecular mechanisms of host-pathogen interaction: entry and survival of mycobacteria in macrophages. Adv Immunol 81: 45-96.
33. Gross GN, Rehm SR, Pierce AK, (1978) The effect of complement depletion on lung clearance of bacteria. J Clin Invest 62: 373-378.
34. Pancholi V, Fontan P, Jin H, (2003) Plasminogen-mediated group A streptococcal adherence to and pericellular invasion of human pharyngeal cells. Microb Pathog 35: 293-303.
35. Lähteenmäki K, Edelman S, Korhonen TK, (2005) Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol 13: 79-85.
36. Boxx GM, Nishiya CT, Kozel TR, Zhang MX, (2009) Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans. Mol Immunol 46: 473-480.
37. Goto H, Kawaoka Y, (1998) A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci USA 95: 10224-10228.
38. Rojas M, Labrador I, Concepción JL, Aldana E, Avilan L, (2008) Characteristics of plasminogen binding to Trypanosoma cruzi epimastigotes. Acta Trop 107: 54-58.
39. Attali C, Durmort C, Vernet T, Di Guilmi AM, (2008) The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect Immun 76: 5350-5356.
40. Monroy V, Amador A, Ruiz B, Espinoza-Cueto P, Xolalpa W, et al. (2000) Binding and activation of human plasminogen by Mycobacterium tuberculosis. Infect Immun 68: 4327-4330.
41. Bergmann S, Wild D, Diekmann O, Frank R, Bracht D, et al. (2003) Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Mol Microbiol 49: 411-423.
42. Mangel WF, Lin BH, Ramakrishnan V, (1990) Characterization of an extremely large, ligand-induced conformational change in plasminogen. Science 248: 69-73.
43. Loving CL, Kennett M, Lee GM, Grippe VK, Merkel TJ, (2007) Murine aerosol challenge model of anthrax. Infect Immun 75: 2689-2698.
44. Fredenburgh JC, Nesheim ME, (1992) Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro. J Biol Chem 267: 26150-26156.
45. Bergmann S, Rohde M, Hammerschmidt S, (2004) Glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pneumoniae is a surface-displayed plasminogen-binding protein. Infect Immun 72: 2416-2419.
46. Pancholi V, Fischetti VA, (1998) alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 273: 14503-14515.
47. Delvecchio VG, Connolly JP, Alefantis TG, Walz A, Quan MA, Patra G, et al. (2006) Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Appl Environ Microbiol 72: 6355-63.
48. Mukhopadhyay S, Akmal A, Stewart AC, Hsia RC, Read TD, (2009) Identification of Bacillus anthracis spore component antigens conserved across diverse Bacillus cereus sensu lato strains. Mol Cell Proteomics 8: 1174-91.
49. Khan AS, Mujer CV, Alefantis TG, Connolly JP, Mayr UB, Walcher P, et al. (2006) Proteomics and bioinformatics strategies to design countermeasures against infectious threat agents. J Chem Inf Model 46: 111-115.
50. McCoy HE, Broder CC, Lottenberg R, (1991) Streptokinases produced by pathogenic group C streptococci demonstrate species-specific plasminogen activation. J Infect Dis 164: 515-521.
51. Schlott B, Gührs KH, Hartmann M, Röcker A, Collen D, (1997) Staphylokinase requires NH2-terminal proteolysis for plasminogen activation. J Biol Chem 272: 6067-6072.
52. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, et al. (1992) A surface protease and the invasive character of plague. Science 258: 1004-1007.
53. Narasaki R, Kuribayashi H, Shimizu K, Imamura D, Sato T, et al. (2005) Bacillolysin MA, a novel bacterial metalloproteinase that produces angiostatin-like fragments from plasminogen and activates protease zymogens in the coagulation and fibrinolysis systems. J Biol Chem 280: 14278-14287.
54. Beaufort N, Wojciechowski P, Sommerhoff CP, Szmyd G, Dubin G, et al. (2008) The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochem J 410: 157-165.
55. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, et al. (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177: 501-510.
56. Feng Y, Pan X, Sun W, Wang C, Zhang H, et al. (2009) Streptococcus suis enolase functions as a protective antigen displayed on the bacterial cell surface. J Infect Dis 200: 1583-1592.
57. Chitlaru T, Gat O, Grosfeld H, Inbar I, Gozlan Y, Shafferman A, (2007) Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome. Infect Immun 75: 2841-2852.
58. Walz A, Mujer CV, Connolly JP, Alefantis T, Chafin R, et al. (2007) Bacillus anthracis secretome time course under host-simulated conditions and identification of immunogenic proteins. Proteome Sci 5: 11.
59. Okumura Y, Yano M, Murakami M, Mori S, Towatari T, Kido H, (1999) The extracellular processing of HIV-1 envelope glycoprotein gp160 by human plasmin. FEBS Lett 442: 39-42.
60. Stie J, Bruni G, Fox D, (2009) Surface-associated plasminogen binding of Cryptococcus neoformans promotes extracellular matrix invasion. PLoS ONE 4: e5780.